Jafron Biomedical Co.,Ltd. (SHE:300529)

Jafron Biomedical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	465.94	1,725	2,810	2,559	2,319	1,575
Trading Asset Securities	2,121	593.07	-	-	150.01	-
Cash & Short-Term Investments	2,587	2,318	2,810	2,559	2,469	1,575
Cash Growth	-17.59%	-17.52%	9.83%	3.62%	56.79%	23.85%
Accounts Receivable	72.51	55.61	81.21	239.64	308.06	215.8
Other Receivables	5.11	3.66	6.51	6.85	6.32	9.78
Receivables	77.62	59.27	87.72	246.49	314.37	225.58
Inventory	344.87	337.79	385	349.13	196.55	120.67
Prepaid Expenses	-	-	0.32	14.55	-	-
Other Current Assets	64.18	68.81	28.5	124.32	75.27	65.31
Total Current Assets	3,074	2,784	3,312	3,293	3,056	1,987
Property, Plant & Equipment	1,900	1,894	1,771	1,672	1,272	905.51
Long-Term Investments	117.37	446.13	116.13	69.45	111.2	98.99
Goodwill	7.01	7.01	12.21	37.81	44.07	44.07
Other Intangible Assets	97.46	97.75	100.37	100.43	101.31	89.89
Long-Term Deferred Tax Assets	43.11	34.97	30.35	36.49	26.54	12.97
Long-Term Deferred Charges	87.56	87.19	94.87	59	35.95	20.42
Other Long-Term Assets	357.31	32.35	107.03	148.22	162.91	58.22
Total Assets	5,683	5,383	5,543	5,417	4,810	3,217
Accounts Payable	123.99	119.19	135.62	128.52	60.76	50.22
Accrued Expenses	73.23	125.07	158.21	157.48	192.98	139.79
Short-Term Debt	54.88	77.51	261.83	317.09	-	-
Current Portion of Long-Term Debt	193.55	192.2	16.79	-	-	-
Current Portion of Leases	-	1.83	3.83	4.73	3.17	-
Current Income Taxes Payable	123.45	56.63	30.52	2.55	23.19	52.14
Current Unearned Revenue	19.87	16.86	37.57	42.3	20.65	26.95
Other Current Liabilities	190.81	177.51	185.03	64.52	85.51	61.73
Total Current Liabilities	779.77	766.79	829.42	717.18	386.26	330.82
Long-Term Debt	1,157	1,110	1,381	936.78	897.37	-
Long-Term Leases	4.02	4.74	11.35	17.34	17.01	-
Long-Term Unearned Revenue	190.05	144.95	151.78	151.66	125.08	51.7
Long-Term Deferred Tax Liabilities	15.7	16.11	16.78	3.12	0.73	0.54
Other Long-Term Liabilities	5.1	6	-	-	-	-
Total Liabilities	2,151	2,049	2,390	1,826	1,426	383.06
Common Stock	798.61	798.61	807.56	807.71	805.5	799.11
Additional Paid-In Capital	240.54	231.26	694.14	678.04	618	347.9
Retained Earnings	3,107	2,918	2,408	2,507	2,336	1,670
Treasury Stock	-733.82	-733.82	-880.63	-509.69	-523.8	-13.52
Comprehensive Income & Other	119.69	119.69	118.63	91.7	123.14	3.08
Total Common Equity	3,532	3,334	3,147	3,574	3,359	2,807
Minority Interest	0.15	0.76	5.4	16.17	24.79	26.82
Shareholders' Equity	3,532	3,335	3,153	3,590	3,384	2,834
Total Liabilities & Equity	5,683	5,383	5,543	5,417	4,810	3,217
Total Debt	1,409	1,386	1,675	1,276	917.55	-
Net Cash (Debt)	1,178	931.31	1,135	1,283	1,552	1,575
Net Cash Growth	-11.77%	-17.97%	-11.49%	-17.34%	-1.47%	23.85%
Net Cash Per Share	1.51	1.19	1.43	1.62	1.93	1.94
Filing Date Shares Outstanding	774.36	774.36	774.47	798.87	815.46	798.53
Total Common Shares Outstanding	774.36	774.36	774.47	798.86	815.46	799.11
Working Capital	2,294	2,017	2,482	2,576	2,669	1,656
Book Value Per Share	4.56	4.31	4.06	4.47	4.12	3.51
Tangible Book Value	3,428	3,229	3,035	3,436	3,213	2,673
Tangible Book Value Per Share	4.43	4.17	3.92	4.30	3.94	3.34
Buildings	-	1,296	1,260	890.61	812.74	555.36
Machinery	-	764.58	678.23	514.6	304.98	212.71
Construction In Progress	-	244.45	122.43	473.99	301.15	262.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.